Buy Rating Reaffirmed on Litigation Progress, Price Target Maintained at $5900
ISG Event to Spotlight Strategies for the AI-Driven Autonomous Enterprise | III Stock News
First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio
Reckitt Announces Expiration and Results of Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044
Reckitt unit Mead Johnson draws USD 400.42 million tenders for 2044 notes buyback
Reckitt Announces Pricing Terms for Previously Announced Any and All Tender Offer and Consent Solicitation for Mead Johnson Nutrition Company Notes due 2044